Your Input: | |||||
| PRDM11 | PR/SET domain 11. (1234 aa) | ||||
| BTG1 | BTG anti-proliferation factor 1. (341 aa) | ||||
| STK17B | Serine/threonine kinase 17b. (372 aa) | ||||
| CFDP1 | Uncharacterized protein. (408 aa) | ||||
| GAS6 | Growth arrest specific 6. (724 aa) | ||||
| PIK3CA | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit. (1068 aa) | ||||
| BCL2L11 | BCL2 like 11. (159 aa) | ||||
| PIK3CG | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma; Belongs to the PI3/PI4-kinase family. (1106 aa) | ||||
| XRCC2 | X-ray repair cross complementing 2. (369 aa) | ||||
| STK17A | Serine/threonine kinase 17a; Belongs to the protein kinase superfamily. (412 aa) | ||||
| ENSAPLP00000032397 | Uncharacterized protein. (220 aa) | ||||
| TP63 | Tumor protein 63 (p63); Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. May be required in conjunction with TP73/p73 for initiation of p53/TP53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. (680 aa) | ||||